JP2011201907A5 - - Google Patents

Download PDF

Info

Publication number
JP2011201907A5
JP2011201907A5 JP2011119894A JP2011119894A JP2011201907A5 JP 2011201907 A5 JP2011201907 A5 JP 2011201907A5 JP 2011119894 A JP2011119894 A JP 2011119894A JP 2011119894 A JP2011119894 A JP 2011119894A JP 2011201907 A5 JP2011201907 A5 JP 2011201907A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
trinol
interphenylene
methano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011119894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011201907A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011201907A publication Critical patent/JP2011201907A/ja
Publication of JP2011201907A5 publication Critical patent/JP2011201907A5/ja
Pending legal-status Critical Current

Links

JP2011119894A 1999-03-18 2011-05-30 ベンゾインデンプロスタグランジンの吸入送達法 Pending JP2011201907A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12499999P 1999-03-18 1999-03-18
US60/124,999 1999-03-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000604834A Division JP4819224B2 (ja) 1999-03-18 2000-03-17 ベンゾインデンプロスタグランジンの吸入送達法

Publications (2)

Publication Number Publication Date
JP2011201907A JP2011201907A (ja) 2011-10-13
JP2011201907A5 true JP2011201907A5 (cg-RX-API-DMAC10.html) 2012-08-16

Family

ID=22417774

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000604834A Expired - Lifetime JP4819224B2 (ja) 1999-03-18 2000-03-17 ベンゾインデンプロスタグランジンの吸入送達法
JP2011119894A Pending JP2011201907A (ja) 1999-03-18 2011-05-30 ベンゾインデンプロスタグランジンの吸入送達法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000604834A Expired - Lifetime JP4819224B2 (ja) 1999-03-18 2000-03-17 ベンゾインデンプロスタグランジンの吸入送達法

Country Status (13)

Country Link
US (2) US6521212B1 (cg-RX-API-DMAC10.html)
EP (1) EP1161234B1 (cg-RX-API-DMAC10.html)
JP (2) JP4819224B2 (cg-RX-API-DMAC10.html)
KR (1) KR100750384B1 (cg-RX-API-DMAC10.html)
CN (1) CN1196479C (cg-RX-API-DMAC10.html)
AT (1) ATE245979T1 (cg-RX-API-DMAC10.html)
AU (1) AU4082700A (cg-RX-API-DMAC10.html)
CA (1) CA2365890C (cg-RX-API-DMAC10.html)
DE (1) DE60004181T2 (cg-RX-API-DMAC10.html)
DK (1) DK1161234T3 (cg-RX-API-DMAC10.html)
ES (1) ES2203449T3 (cg-RX-API-DMAC10.html)
PT (1) PT1161234E (cg-RX-API-DMAC10.html)
WO (1) WO2000054758A2 (cg-RX-API-DMAC10.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
DE10163697A1 (de) * 2001-12-21 2003-07-03 Studiengesellschaft Kohle Mbh Reversible Speicherung von Wasserstoff mit Hilfe von dotierten Alkalimetallaluminiumhydriden
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US7417070B2 (en) 2003-05-22 2008-08-26 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
US20090124697A1 (en) * 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
ES2347254T3 (es) * 2003-12-16 2010-10-27 United Therapeutics Corporation Utilizacion de treprostinil para el tratamiento de las lesiones isquemicas.
WO2005058329A1 (en) * 2003-12-16 2005-06-30 United Therapeutics Corporation Use of treprostinil to improve kidney functions
KR101186029B1 (ko) * 2004-04-12 2012-09-27 유나이티드 쎄러퓨틱스 코포레이션 신경병증성 당뇨병성 족부 궤양을 치료하기 위한트레프로스티닐의 용도
WO2006063215A2 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
EP1965803A1 (en) * 2005-12-05 2008-09-10 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
ES2707548T3 (es) * 2006-05-15 2019-04-04 United Therapeutics Corp Administración de treprostinil utilizando un inhalador de dosis medida
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
WO2008049000A2 (en) * 2006-10-18 2008-04-24 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CN102648916A (zh) * 2007-02-09 2012-08-29 联合治疗公司 用于间质性肺病和哮喘的曲前列尼治疗
EP2252570B1 (en) 2007-12-17 2017-04-05 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin ®
EP2300408B1 (en) 2008-05-08 2016-04-13 United Therapeutics Corporation Process for the preparation of treprostinil monohydrate and its use for storage and shipping
US20120177693A1 (en) * 2008-09-25 2012-07-12 Aradigm Corporation Deep lung pulmonary delivery of treprostinil
KR101544246B1 (ko) * 2009-05-07 2015-08-12 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 유사체의 고체 제제
KR101508047B1 (ko) 2010-03-15 2015-04-06 유나이티드 세러퓨틱스 코오포레이션 폐고혈압의 치료
US8481782B2 (en) 2010-06-03 2013-07-09 United Therapeutics Corporation Treprostinil production
WO2012118943A1 (en) 2011-03-02 2012-09-07 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
AU2013351934B2 (en) * 2012-11-30 2018-03-29 Insmed Incorporated Prostacylin compositions and methods for using the same
KR102347340B1 (ko) 2013-03-14 2022-01-06 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐의 고체 형태
CN109608326A (zh) 2013-03-15 2019-04-12 联合治疗公司 曲前列环素的盐
KR102238501B1 (ko) 2013-03-25 2021-04-08 유나이티드 세러퓨틱스 코오포레이션 링커 티올 및 peg화된 형태를 갖는 프로스타시클린 화합물의 제조 방법
MX382833B (es) 2013-10-25 2025-03-13 Insmed Inc Compuestos derivados de prostaciclinas, y el uso de los mismo para el tratamiento de la hipertension pulmonar
EP3164155B1 (en) 2014-06-13 2022-02-09 United Therapeutics Corporation Treprostinil formulations
JP6224872B1 (ja) 2014-10-20 2017-11-01 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン誘導体を生成するための中間体の合成
EP3221291B1 (en) 2014-11-18 2021-03-31 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
US10632129B2 (en) 2014-12-03 2020-04-28 Steadymed Ltd. Preservative-free treprostinil formulations and methods and devices for use with same
RU2593016C2 (ru) * 2014-12-15 2016-07-27 Федеральное государственное бюджетное учреждение науки Институт теоретической и прикладной механики им. С.А. Христиановича Сибирского отделения Российской академии наук (ИТПМ СО РАН) Способ лечения артериальной гипертензии путем ингаляционного введения аэрозоля гипотензивного препарата
EP3452170A4 (en) 2016-05-05 2020-04-01 Liquidia Technologies, Inc. DRY POWDER OF TREPROSTINIL FOR THE TREATMENT OF PULMONARY HYPERTENSION
CA3038276A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
EP3554507A1 (en) 2016-12-14 2019-10-23 Respira Therapeutics, Inc. Methods and compositions for treatment of pulmonary hypertension and other lung disorders
US10799653B2 (en) 2017-01-09 2020-10-13 United Therapeutics Corporation Aerosol delivery device and method for manufacturing and operating the same
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
EA202190552A1 (ru) 2018-09-18 2021-06-18 Эли Лилли Энд Компани Эрбуминовая соль трепростинила
IL281867B2 (en) 2018-10-05 2024-07-01 Xenotherapeutics Inc Xenotransplantation products and methods
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
BR112021021775A2 (pt) 2019-04-29 2022-01-04 Insmed Inc Composições de pó seco de pró-fármacos de treprostinil e métodos de uso destas
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
EP4017588A1 (en) 2019-08-23 2022-06-29 United Therapeutics Corporation Treprostinil prodrugs
US11339110B2 (en) 2019-12-19 2022-05-24 Chirogate International Inc. Efficient crystallization process for preparing ultrapure Treprostinil and crystal prepared therefrom
US11826327B2 (en) 2020-04-17 2023-11-28 United Therapeutics Corporation Treatment for interstitial lung disease
CA3180230A1 (en) 2020-06-09 2021-12-16 Hitesh Batra Fumaryl diketopiperidine prodrugs of treprostinil
US11447440B2 (en) 2020-10-29 2022-09-20 Chirogate International Inc. Treprostinil monohydrate crystals and methods for preparation thereof
US11826328B2 (en) 2020-12-14 2023-11-28 United Therapeutics Corporation Stable treprostinil prodrugs
AU2022229367A1 (en) 2021-03-03 2023-09-14 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
AU2023219692A1 (en) 2022-02-08 2024-08-01 United Therapeutics Corporation Treprostinil iloprost combination therapy
WO2023206444A1 (zh) 2022-04-29 2023-11-02 兆科药业（广州）有限公司 一种曲前列尼尔软雾吸入剂
EP4651879A1 (en) 2023-01-18 2025-11-26 United Therapeutics Corporation Treatment of pulmonary arterial hypertension
KR20250139830A (ko) 2023-01-19 2025-09-23 유나이티드 쎄러퓨틱스 코포레이션 트레프로스티닐 유사체

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338457A (en) * 1980-02-28 1982-07-06 The Upjohn Company Composition and process
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4306076A (en) * 1980-04-23 1981-12-15 The Upjohn Company Inter-phenylene CBA compounds
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
US4349689A (en) * 1980-12-22 1982-09-14 The Upjohn Company Methano carbacyclin analogs
ZA851337B (en) * 1984-03-08 1985-10-30 Upjohn Co Interphenylene carbacyclin derivatives
CA1241324A (en) 1984-03-08 1988-08-30 Paul A. Aristoff Interphenylene carbacyclin derivatives
AU587472B2 (en) * 1985-05-22 1989-08-17 Liposome Technology, Inc. Liposome inhalation method and system
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
DK299089A (da) * 1988-06-17 1989-12-18 Wellcome Found Anvendelse af prostaglandiner til fremstilling af laegemidler
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
CA2312729C (en) * 1997-11-14 2006-05-23 United Therapeutics Corporation Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

Similar Documents

Publication Publication Date Title
JP2011201907A5 (cg-RX-API-DMAC10.html)
JP2017513836A5 (cg-RX-API-DMAC10.html)
JP2015527402A5 (cg-RX-API-DMAC10.html)
JP2013520405A5 (cg-RX-API-DMAC10.html)
JP2013518107A5 (cg-RX-API-DMAC10.html)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2012255026A5 (cg-RX-API-DMAC10.html)
JP2016534142A5 (cg-RX-API-DMAC10.html)
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2013542247A5 (cg-RX-API-DMAC10.html)
JP2013509429A5 (cg-RX-API-DMAC10.html)
JP2016530259A5 (cg-RX-API-DMAC10.html)
JP2016534153A5 (cg-RX-API-DMAC10.html)
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
JP2017531038A5 (cg-RX-API-DMAC10.html)
JP2014530801A5 (cg-RX-API-DMAC10.html)
JP2013508279A5 (cg-RX-API-DMAC10.html)
HRP20171512T1 (hr) Derivati betulina
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
JP2012533517A5 (cg-RX-API-DMAC10.html)
EA201792071A2 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
AR090592A1 (es) Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil}amino)-1-hidroxietil]-8-hidroxiquinolin-2(1h)-ona
ME02405B (me) Spojevi pirazola као inhibitori sglt1
JP2015516419A5 (cg-RX-API-DMAC10.html)
JP2014509637A5 (cg-RX-API-DMAC10.html)